RaedleJFriedlWEngelsHKoenigRTrojanJZeuzemS. A de novo deletion of chromosome 5q causing familial adenomatous polyposis, dysmorphic features, and mild mental retardation. Am J Gastroenterol. 2001;96:3016-3020.
2.
OfnerLRaedleJWindpassingerC. Phenotypic and molecular characterisation of a de novo 5q deletion that includes the APC gene. J Hum Genet. 2006;51:141-146.
3.
MeffordHCBatshawMLHoffmanEP. Genomics, intellectual disability, and autism. N Engl J Med. 2012;366:733-743.
4.
ManningMHudginsL; Professional Practice and Guidelines Committee. Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med. 2010;12:742-745.
5.
MichelsonDJShevellMISherrEHMoeschlerJBGropmanALAshwalS. Evidence report: Genetic and metabolic testing on children with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2011;77:1629-1635.
6.
ShenYDiesKAHolmIA; Autism Consortium Clinical Genetics/DNA Diagnostics Collaboration. Clinical genetic testing for patients with autism spectrum disorders. Pediatrics. 2010;125:e727-e735.
7.
AdamsSACoppingerJSaittaSC. Impact of genotype-first diagnosis: the detection of microdeletion and microduplication syndromes with cancer predisposition by aCGH. Genet Med. 2009;11:314-322.
8.
PichertGMohammedSNAhnJWOgilvieCMIzattL. Unexpected findings in cancer predisposition genes detected by array comparative genomic hybridization: what are the issues?J Med Genet. 2011;48:535-539.
9.
SchaafCPScottDAWiszniewskaJBeaudetAL. Identification of incestuous parental relationships by SNP-based DNA microarrays. Lancet. 2011;377:555-556.
10.
TrakadisYShevellM. Microarray as a first genetic test in global developmental delay: a cost-effectiveness analysis. Dev Med Child Neurol. 2011;53:994-999.
